ClinConnect ClinConnect Logo
Search / Trial NCT05921396

Nasal Obstruction Compared by Rhinomanometry and Nasal Inspiratory Peak Flow After Endoscopic Nasal Surgery

Launched by UNIVERSITY HOSPITAL OSTRAVA · Jun 16, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Pituitary Adenoma Nasal Surgery Rhinomanometry Nasal Inspiratory Peak Flow Endoscopic Nasal Surgery

ClinConnect Summary

This clinical trial is investigating how well a simple test called nasal inspiratory peak flow can measure how open a person's nose is, especially before and after they have surgery for a pituitary adenoma. The researchers want to see if this easier test is just as good as a more complex test called rhinomanometry, which measures airflow through the nose. This study is currently looking for participants aged 18 and older who are scheduled for surgery to remove a pituitary adenoma using a method that goes through the nose.

To be part of the trial, patients must be eligible based on certain criteria. They should not have had previous surgery on their nose or nearby areas, nor should they have any existing nasal diseases or problems with their sense of smell. If you qualify and choose to participate, you can expect to undergo these tests to see how well your nose is functioning before and after your surgery. This research could help improve how doctors assess nasal blockage in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age over 18 years
  • patients with pituitary adenoma indicated to endoscopic transnasal extirpation of the pituitary adenoma
  • Exclusion Criteria:
  • patients after surgery of the nasal cavity or base of the skull
  • patients with nasal disease and paranasal sinuses
  • patients with olfactory disorders before surgery
  • patients with nasal septal deviation that requires septoplasty

About University Hospital Ostrava

University Hospital Ostrava is a leading medical research institution located in Ostrava, Czech Republic, dedicated to advancing healthcare through innovative clinical trials and research initiatives. As a prominent sponsor of clinical studies, the hospital combines cutting-edge medical technology with a commitment to patient-centered care, fostering collaborations among multidisciplinary teams of healthcare professionals and researchers. With a focus on ethical standards and regulatory compliance, University Hospital Ostrava aims to contribute to the development of new therapies and improve treatment outcomes across various medical fields. Its robust research infrastructure and dedication to scientific excellence position it as a key player in the advancement of medical knowledge and patient care.

Locations

Ostrava, Moravian Silesian Region, Czechia

Patients applied

0 patients applied

Trial Officials

Jakub Lubojacký, MD

Principal Investigator

University Hospital Ostrava

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported